{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:54:35Z","timestamp":1774619675285,"version":"3.50.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ejim.2023.06.026","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T01:05:12Z","timestamp":1688519112000},"page":"21-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Axial Spondyloarthritis: Evolving concepts regarding the disease's diagnosis and treatment"],"prefix":"10.1016","volume":"117","author":[{"given":"Alexandros A.","family":"Drosos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliki I.","family":"Venetsanopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi V.","family":"Voulgari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10089","key":"10.1016\/j.ejim.2023.06.026_bib0001","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)31591-4","article-title":"Axial spondyloarthritis","volume":"390","author":"Sieper","year":"2017","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ejim.2023.06.026_bib0002","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1136\/annrheumdis-2021-221035","article-title":"Axial spondyloarthritis","volume":"80","author":"Navarro-Comp\u00e1n","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ejim.2023.06.026_bib0003","doi-asserted-by":"crossref","first-page":"660","DOI":"10.55563\/clinexprheumatol\/yycy0o","article-title":"Incidence of spondyloarthritis and its subtypes: a systematic review","volume":"39","author":"Alamanos","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"No 1","key":"10.1016\/j.ejim.2023.06.026_bib0004","article-title":"Ankylosing Spondylitis","volume":"Vol 27","author":"Jimenea","year":"1979","journal-title":"Henry Ford Hosp Med Journal"},{"issue":"4 Suppl 55","key":"10.1016\/j.ejim.2023.06.026_bib0005","first-page":"S3","article-title":"How did ankylosing spondylitis become a separate disease?","volume":"27","author":"Benedek","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.ejim.2023.06.026_bib0006","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. a proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.026_bib0007","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/art.1780280107","article-title":"Spondylitic disease without radiologic evidence of sacroiliitis in relatives of HLA-B27 positive ankylosing spondylitis patients","volume":"28","author":"Khan","year":"1985","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.026_bib0008","first-page":"85","article-title":"[Criteria of the classification of spondylarthropathies]","volume":"57","author":"Amor","year":"1990","journal-title":"Rev Rhum Mal Osteoartic"},{"issue":"10","key":"10.1016\/j.ejim.2023.06.026_bib0009","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.026_bib0010","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/ard.2009.108217","article-title":"The development of assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.026_bib0011","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.026_bib0012","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jbspin.2019.04.006","article-title":"Structural progression in axial spondyloarthritis","volume":"87","author":"Aouad","year":"2020","journal-title":"Joint Bone Spine"},{"issue":"10","key":"10.1016\/j.ejim.2023.06.026_bib0013","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1002\/art.27571","article-title":"The diagnostic utility of magnetic resonance imaging in spondylarthritis: an international multicenter evaluation of one hundred eighty-seven subjects","volume":"62","author":"Weber","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.ejim.2023.06.026_bib0014","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1136\/annrheumdis-2015-208642","article-title":"Defining active sacroiliitis on MRI for classification of axial Spondyloarthritis: update by the ASAS MRI working group","volume":"75","author":"Lambert","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.026_bib0015","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1136\/annrheumdis-2015-207823","article-title":"Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis?","volume":"75","author":"de Hooge","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ejim.2023.06.026_bib0016","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1136\/annrheumdis-2019-215589","article-title":"MRI lesions in the sacroiliac joints of patients with Spondyloarthritis: an update of definitions and validation by the ASAS MRI working group","volume":"78","author":"Maksymowych","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.026_bib0017","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41584-020-00552-4","article-title":"Axial Spondyloarthritis: concept, construct, classification and implications for therapy","volume":"17","author":"Robinson","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.ejim.2023.06.026_bib0018","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.2003.011247","article-title":"How to diagnose axial spondyloarthritis early","volume":"63","author":"Rudwaleit","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.ejim.2023.06.026_bib0019","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.mayocp.2020.02.007","article-title":"Recognizing Axial Spondyloarthritis: a guide for primary care","volume":"95","author":"Magrey","year":"2020","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.026_bib0020","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.2214\/AJR.17.19404","article-title":"Postpartum bone marrow edema at the sacroiliac joints may mimic sacroiliitis of axial Spondyloarthritis on MRI","volume":"211","author":"Agten","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.026_bib0021","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/art.40475","article-title":"Magnetic resonance imaging of the sacroiliac joints indicating sacroiliitis according to the assessment of SpondyloArthritis international society definition in healthy individuals, runners, and women with postpartum back pain","volume":"70","author":"de Winter","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.026_bib0022","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/annrheumdis-2020-217095","article-title":"High prevalence of spondyloarthritis-like MRI lesions in postpartum women: a prospective analysis in relation to maternal, child and birth characteristics","volume":"79","author":"Renson","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ejim.2023.06.026_bib0023","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/annrheumdis-2019-215553","article-title":"Frequency of MRI changes suggestive of axial spondyloarthritis in the axial skeleton in a large population-based cohort of individuals aged <45 years","volume":"79","author":"Baraliakos","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ejim.2023.06.026_bib0024","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/art.42145","article-title":"Progressive increase in sacroiliac joint and spinal lesions detected on magnetic resonance imaging in healthy individuals in relation to age","volume":"74","author":"Renson","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.026_bib0025","first-page":"58","article-title":"Bertolotti syndrome: a not-to-miss cause of chronic low back pain in young adults","volume":"45","author":"Pelechas","year":"2020","journal-title":"Acta Rheumatol Port"},{"issue":"4","key":"10.1016\/j.ejim.2023.06.026_bib0026","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/BOR.0000000000000718","article-title":"MRI of the sacroiliac joints: what is and what is not sacroiliitis?","volume":"32","author":"\u00d8stergaard","year":"2020","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.026_bib0027","first-page":"29","article-title":"are we overcalling sacroiliitis on MRI? differential diagnosis that every rheumatologist should know \u2013 Part I","volume":"44","author":"Campos-Correia","year":"2019","journal-title":"Acta Rheumatol Port"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.026_bib0028","first-page":"42","article-title":"Are We Overcalling Sacroillitis on MRI? Differential diagnosis that every rheumatologist should know - Part II","volume":"44","author":"Campos-Correia","year":"2019","journal-title":"Acta Rheumatol Port."},{"issue":"2","key":"10.1016\/j.ejim.2023.06.026_bib0029","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/annrheumdis-2021-220136","article-title":"Choose wisely: imaging for diagnosis of axial spondyloarthritis","volume":"81","author":"Diekhoff","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ejim.2023.06.026_bib0030","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/art.42143","article-title":"Sacroiliac bone marrow edema: innocent until proven guilty?","volume":"74","author":"Ward","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.ejim.2023.06.026_bib0031","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1445-5994.2007.01491.x","article-title":"Human leucocyte antigen-B27 and ankylosing spondylitis","volume":"37","author":"Brown","year":"2007","journal-title":"Inter Med J"},{"issue":"8","key":"10.1016\/j.ejim.2023.06.026_bib0032","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.autrev.2011.01.011","article-title":"What is the role of HLA-B27 in spondyloarthropathies?","volume":"10","author":"Chatzikyriakidou","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.ejim.2023.06.026_bib0033","first-page":"735","article-title":"Non-HLA genes in ankylosing spondylitis: what meta-analyses have shown?","volume":"32","author":"Chatzikyriakidou","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.026_bib0034","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/art.42289","article-title":"Both disease activity and HLA-B27 status are associated with gut microbiome dysbiosis in spondyloarthritis patients","volume":"75","author":"Berland","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.ejim.2023.06.026_bib0035","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2017.188","article-title":"Enthesitis: from pathophysiology to treatment","volume":"13","author":"Schett","year":"2017","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.ejim.2023.06.026_bib0036","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3389\/fimmu.2018.02668","article-title":"The early phases of ankylosing spondylitis: emerging insights from clinical and basic science","volume":"9","author":"Watad","year":"2018","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.ejim.2023.06.026_bib0037","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3390\/biom10101461","article-title":"Understanding the Pathogenesis of Spondyloarthritis","volume":"10","author":"Sharip","year":"2020","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.026_bib0038","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41584-021-00625-y","article-title":"Ankylosing spondylitis: an autoimmune or autoinflammatory disease?","volume":"17","author":"Mauro","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"10.1016\/j.ejim.2023.06.026_bib0039","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1136\/annrheumdis-2018-213654","article-title":"Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation?","volume":"78","author":"Siebert","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.026_bib0040","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1056\/NEJMra1909094","article-title":"Reframing immune-mediated inflammatory diseases through signature cytokine hubs","volume":"385","author":"Schett","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.026_bib0041","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.55563\/clinexprheumatol\/jlyd1l","article-title":"One year in review 2021: axial spondyloarthritis","volume":"39","author":"Cardelli","year":"2021","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl4","key":"10.1016\/j.ejim.2023.06.026_bib0042","doi-asserted-by":"crossref","first-page":"iv79","DOI":"10.1093\/rheumatology\/keaa435","article-title":"Treatment strategies in axial Spondyloarthritis: what, when and how?","volume":"59","author":"Fragoulis","year":"2020","journal-title":"Rheumatology"},{"issue":"Suppl 6","key":"10.1016\/j.ejim.2023.06.026_bib0043","doi-asserted-by":"crossref","first-page":"vi29","DOI":"10.1093\/rheumatology\/keab523","article-title":"New developments in ankylosing spondylitis-status in 2021","volume":"60","author":"Klavdianou","year":"2021","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.ejim.2023.06.026_bib0044","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-023-01097-7","article-title":"Have therapeutics enhanced our knowledge of axial Spondyloarthritis?","volume":"25","author":"Harrison","year":"2023","journal-title":"Curr Rheumatol Rep"},{"issue":"9313","key":"10.1016\/j.ejim.2023.06.026_bib0045","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ejim.2023.06.026_bib0046","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/ard.2003.014258","article-title":"Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study","volume":"62","author":"Temekonidis","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.026_bib0047","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial Spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.026_bib0048","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/ard-2022-223298","article-title":"Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis","volume":"82","author":"Webers","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.ejim.2023.06.026_bib0049","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard.2005.040758","article-title":"First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis","volume":"65","author":"Braun","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ejim.2023.06.026_bib0050","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/ard.2005.041137","article-title":"ASsessment in AS' international working group; European League Against Rheumatism. ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"65","author":"Zochling","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.026_bib0051","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1136\/ard.2011.151027","article-title":"2010 update of the ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"70","author":"Braun","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.026_bib0052","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ejim.2023.06.026_bib0053","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41584-022-00798-0","article-title":"GRAPPA treatment recommendations domain subcommittees. group for research and assessment of psoriasis and psoriatic arthritis (grappa): updated treatment recommendations for psoriatic arthritis 2021","volume":"18","author":"Coates","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"10.1016\/j.ejim.2023.06.026_bib0054","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/acr.24184","article-title":"Tumor necrosis factor inhibitor dose reduction for axial Spondyloarthritis: a systematic review and meta-analysis of randomized controlled trials","volume":"73","author":"Lawson","year":"2021","journal-title":"Arthritis Care Res"},{"issue":"9","key":"10.1016\/j.ejim.2023.06.026_bib0055","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1136\/annrheumdis-2022-222324","article-title":"Treatment with tumour necrosis factor inhibitors is associated with a time-shifted retardation of radiographic spinal progression in patients with axial spondyloarthritis","volume":"81","author":"Torgutalp","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ejim.2023.06.026_bib0056","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/art.42144","article-title":"Treatment with tumor necrosis factor inhibitors is associated with a time-shifted retardation of radiographic sacroiliitis progression in patients with axial Spondyloarthritis: 10-year results from the german Spondyloarthritis inception cohort","volume":"74","author":"Torgutalp","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.ejim.2023.06.026_bib0057","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/art.42149","volume":"74","author":"Bruckmann","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.ejim.2023.06.026_bib0058","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/acr.24616","volume":"74","author":"Ben-Shabat","year":"2022","journal-title":"Arthritis Care Res"},{"issue":"12","key":"10.1016\/j.ejim.2023.06.026_bib0059","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the bath ankylosing spondylitis disease activity index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"issue":"7","key":"10.1016\/j.ejim.2023.06.026_bib0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11926-015-0522-3","article-title":"Clinical tools to assess and monitor Spondyloarthritis","volume":"17","author":"Landew\u00e9","year":"2015","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"10.1016\/j.ejim.2023.06.026_bib0061","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/rheumatology\/38.9.878","article-title":"Defining disease activity in ankylosing spondylitis: is a combination of variables (bath ankylosing spondylitis disease activity index) an appropriate instrument?","volume":"38","author":"Calin","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.ejim.2023.06.026_bib0062","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","article-title":"Assessment of SpondyloArthritis international society (ASAS). ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis","volume":"68","author":"van der Heijde","year":"2009","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.ejim.2023.06.026_bib0063","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Assessment of SpondyloArthritis international society. development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Ann RHEUM Dis."},{"issue":"1","key":"10.1016\/j.ejim.2023.06.026_bib0064","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","article-title":"Assessment of SpondyloArthritis international society. ankylosing spondylitis disease activity score (asdas): defining cut-off values for disease activity states and improvement scores","volume":"70","author":"Machado","year":"2011","journal-title":"Ann Rheum Dis."},{"issue":"Suppl 2","key":"10.1016\/j.ejim.2023.06.026_bib0065","doi-asserted-by":"crossref","first-page":"ii49","DOI":"10.1136\/ard.2004.034165","article-title":"Psoriatic arthritis assessment tools in clinical trials","volume":"64","author":"Mease","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ejim.2023.06.026_bib0066","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3899\/jrheum.170449","article-title":"Minimal disease activity as a treatment target in psoriatic arthritis: a review of the literature","volume":"45","author":"Gossec","year":"2018","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.ejim.2023.06.026_bib0067","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1136\/annrheumdis-2017-212076","article-title":"Measurement properties of the ASAS health index: results of a global study in patients with axial and peripheral spondyloarthritis","volume":"77","author":"Kiltz","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ejim.2023.06.026_bib0068","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.3899\/jrheum.200025","article-title":"Performance of the ASAS health index for the evaluation of Spondyloarthritis in daily practice","volume":"47","author":"Alonso-Castro","year":"2020","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ejim.2023.06.026_bib0069","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fmed.2018.00062","article-title":"Comorbidities in Spondyloarthritis","volume":"5","author":"Molt\u00f3","year":"2018","journal-title":"Front Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523002212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620523002212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:40:06Z","timestamp":1760607606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620523002212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":69,"alternative-id":["S0953620523002212"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2023.06.026","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Axial Spondyloarthritis: Evolving concepts regarding the disease's diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2023.06.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}